Research Topics
| Evelina TacconelliSummaryAffiliation: Catholic University Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Identifying risk factors for infections: the role of meta-analysesEvelina Tacconelli
Department of Infectious Diseases, Universita Cattolica Sacro Cuore, Roma, Italy
Infect Dis Clin North Am 23:211-24. 2009....
Nosocomial acquisition of methicillin-resistant Staphyloccocus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) Enterobacteriaceae in hospitalised patients: a prospective multicenter studyGiulia De Angelis
Department of Infectious Diseases, Universita Cattolica del Sacro Cuore, Largo F, VITO, 1 00168 Rome, Italy
BMC Infect Dis 12:74. 2012....
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based studyEvelina Tacconelli
Department of Infectious Diseases, Universita Cattolica del Sacro Cuore, Rome, Italy
Antimicrob Agents Chemother 53:4264-9. 2009..Identifying ARB colonization early during antibiotic therapy could target a high-risk hospitalized population that may benefit from intervention to decrease the risk of subsequent nosocomial infections...
Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settingsEvelina Tacconelli
Department of Infectious Diseases, Universita Cattolica Sacro Cuore, Rome, Italy
Curr Opin Infect Dis 22:352-8. 2009..This review explores recent evidence on the association between antibiotics usage and resistance...
Pneumonia due to methicillin-resistant Staphylococcus aureus: clinical features, diagnosis and managementEvelina Tacconelli
Department of Infectious Diseases, Universita Cattolica Sacro Cuore, Rome, Italy
Curr Opin Pulm Med 15:218-22. 2009..The review highlights the clinical findings and the management of community-acquired, health-care associated and nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA)...
Vancomycin-resistant enterococci (VRE): transmission and controlEvelina Tacconelli
Division Infectious Diseases, Catholic University, Largo F Vito, 100168, Rome, Italy
Int J Antimicrob Agents 31:99-106. 2008..Future prospective comparative studies of infection control approaches in different epidemiological situations might be useful...
New strategies to identify patients harbouring antibiotic-resistant bacteria at hospital admissionE Tacconelli
Department of Infectious Diseases, Catholic University, Rome, Italy
Clin Microbiol Infect 12:102-9. 2006..Current studies are analysing risk-factors for harbouring multiresistant Gram-negative bacteria at hospital admission...
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complexEvelina Tacconelli
Department of Infectious Diseases, Universita Cattolica Sacro Cuore, 00168 Rome, Italy
J Antimicrob Chemother 62:1130-7. 2008....
Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureusE Tacconelli
Department of Infectious Diseases, Catholic University, Rome, Italy
J Hosp Infect 69:337-44. 2008..02). Our data suggest that use of vancomycin as prophylactic agent for cerebrospinal shunt placement reduces the rate of shunt infections in the context of high prevalence of MRSA...
Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysisEvelina Tacconelli
Department of Infectious Diseases, Catholic University, Rome, Italy
J Antimicrob Chemother 61:26-38. 2008..A systematic review was performed to determine whether antibiotic exposure is a risk factor for the isolation of MRSA...
Antimicrobial therapy of Staphylococcus aureus bloodstream infectionEvelina Tacconelli
Universita Cattolica S Cuore, Istituto Malattie Infettive, Largo F Vito 8, 00168 Roma, Italy
Expert Opin Pharmacother 8:2505-18. 2007..The review summarises evidence on present therapeutic options for the treatment of S. aureus BSI...
Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysisEvelina Tacconelli
Department of Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy
Lancet Infect Dis 9:546-54. 2009....
Screening and isolation for infection controlE Tacconelli
Department of Infectious Diseases, Universita Cattolica Sacro Cuore, Rome, Italy
J Hosp Infect 73:371-7. 2009..Based on these studies, definitive recommendations cannot be made...
National guidelines for decolonization of methicillin-resistant Staphylococcus aureus carriers: the implications of recent experience in the NetherlandsEvelina Tacconelli
Department of Infectious Disease, Universita Cattolica, Largo F Vito 1, 00168, Rome, Italy
J Antimicrob Chemother 66:2195-8. 2011....
Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control studyE Tacconelli
Department of Infectious, Catholic University, Rome, Italy
Clin Infect Dis 33:1628-35. 2001..Mortality rates were 25% among case patients and 18% among control patients, and they were significantly higher among patients who presented with concomitant pneumonia and a high Acute Physiology and Chronic Health Evaluation III score...
Methicillin-resistant Staphylococcus aureus: source control and surveillance organizationE Tacconelli
Department of Infectious Diseases, Catholic University, Rome, Italy
Clin Microbiol Infect 15:31-8. 2009..The existing evidence does not support the wide application of rapid molecular screening for MRSA...
Fighting antibiotic resistance all over EuropeEvelina Tacconelli
Department of Infectious Diseases, Universita Cattolica del Sacro Cuore, Largo F Vito, 1 00168 Rome, Italy
Expert Rev Anti Infect Ther 8:761-3. 2010..The participation of a such significant number of scientists presented a unique opportunity for discussion on several clinical and research topics...
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapyMario Tumbarello
Department of Infectious Diseases, Catholic University, Rome, Italy
BMC Infect Dis 4:46. 2004..Interestingly, older age did not seem to significantly affect the long-term virological outcome of HAART treated subjects...
Older HIV-positive patients in the era of highly active antiretroviral therapy: changing of a scenarioMario Tumbarello
Department of Infectious Diseases, Catholic University, Rome, Italy
AIDS 17:128-31. 2003
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patientsMario Tumbarello
Department of Infectious Diseases and Microbiology, Catholic University, Largo A Gemelli 8, 00168 Roma, Italy
J Antimicrob Chemother 50:375-82. 2002..To define the incidence, risk factors and short-term predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients...
Anti-retroviral therapy with protease inhibitors decreases virulence enzyme expression in vivo by Candida albicans without selection of avirulent fungus strains or decreasing their anti-mycotic susceptibilityFlavia De Bernardis
Department of Infectious, Parasitic and Immune Mediated Diseases, Istituto Superiore di Sanita, Viale Regina Elena 299, Rome 00161, Italy
FEMS Immunol Med Microbiol 41:27-34. 2004..While further demonstrating that HIV-PI inhibit Sap expressions, our results do not support the view that the mentioned inhibition could eliminate Candida or its selection of the oral cavity...
Risk scoring and bloodstream infectionsEvelina Tacconelli
Istituto Malattie Infettive, Universita Cattolica S Cuore, Rome, Italy
Int J Antimicrob Agents 30:S88-92. 2007..New randomised clinical trials are needed to study the efficacy of clinical scores in reducing BSI-associated morbidity and mortality...
How could we reduce antibiotic use in critically ill patients?Giulia De Angelis
Department of Infectious Diseases, Universita Cattolica, Largo F Vito 1, 00168 Rome, Italy
Infect Disord Drug Targets 11:376-83. 2011..To optimize antibiotic use in the ICU and to fight against the spread of resistance, it is extremely important to adopt a multifaceted approach including ASP...
Increased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapyKatleen de Gaetano Donati
Department of Infectious Diseases, Catholic University, Rome, Italy
AIDS 17:765-8. 2003
Azole susceptibility patterns and genetic relationship among oral Candida strains isolated in the era of highly active antiretroviral therapyEvelina Tacconelli
Department of Infectious Diseases, Catholic University, Rome, Italy
J Acquir Immune Defic Syndr 31:38-44. 2002..Our findings demonstrate that most cases of HIV-associated OPC observed in the HAART era are caused by azole-susceptible strains. The reversion of an isolate from azole resistant to azole susceptible is related to strain replacement...
In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coliTeresa Spanu
Institute of Microbiology, Catholic University, Rome, Italy
Antimicrob Agents Chemother 56:4516-8. 2012..The reported limited experience underlines the risk of occurrence of a tigecycline MIC increase under treatment pressure...
Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapiesM Tumbarello
Department of Infectious Diseases, Catholic University, Rome, Italy
Eur J Clin Microbiol Infect Dis 20:498-501. 2001..These results indicate that MAC infections, although considerably less frequent in the HAART era, are still responsible for cases of severe disease...
Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphomaAntonella Cingolani
Institute of Infectious Diseases, Catholic University, Rome, Italy
AIDS 24:2408-12. 2010....
Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcomeS Bertagnolio
Department of Infectious Diseases, Catholic University Medical School, Rome, Italy
J Chemother 16:172-8. 2004..Despite the use of HAART, this disease still represents a severe complication of advanced stage of AIDS...
Morbidity associated with central venous catheter-use in a cohort of 212 hospitalized subjects with HIV infectionE Tacconelli
Department of Infectious Diseases, Catholic University, Rome, Italy
J Hosp Infect 44:186-92. 2000..01); 2) low number of circulating CD4+ cells (P = 0.04); 3) high APACHE III score (P = 0. 04). Doctors responsible for AIDS patients should carefully consider the relative risks and benefits of CVC insertion in an individual patient...
Correlation between cidofovir-associated uveitis and failing immunorestoration during HAARTE Tacconelli
Department of Infectious Diseases, Catholic University, Rome, Italy
Eur J Clin Microbiol Infect Dis 22:114-7. 2003..Thus, cidofovir-associated uveitis seems to occur more frequently in AIDS patients with retinitis in whom highly active antiretroviral therapy fails to restore immunity...
Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV-infected subjectsK de Gaetano Donati
Dept Infectious Diseases, Catholic University, L go A Gemelli 8, 00168 Rome, Italy
J Chemother 15:60-5. 2003..This study establishes that a significant reduction in bacterial infection incidence occurred in HIV-infected subjects when HAART became the standard therapy for HIV infection...
Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcomeM Tumbarello
Dept of Infectious Diseases, Catholic University, Rome, Italy
Eur Respir J 17:636-40. 2001..Although the incidence of nosocomial bacterial pneumonia, as well of other opportunistic infections, decreased considerably in the era of highly active antiretroviral therapy, it still represents an important cause of mortality...
Epidemiology, medical outcomes and costs of catheter-related bloodstream infections in intensive care units of four European countries: literature- and registry-based estimatesE Tacconelli
Department of Infectious Diseases, Catholic University, Rome, Italy
J Hosp Infect 72:97-103. 2009..9 to euro163.9 million associated costs. Discrepancies are mainly explained by the heterogeneous quality of epidemiological studies, as well as the variety of national clinical practices...
Surgical site infections in HIV-infected patients: results from an Italian prospective multicenter observational studyC M J Drapeau
2nd Infectious Diseases Division, National Institute for Infectious Diseases, L Spallanzani, Via Portuense 292, 00149, Rome, Italy
Infection 37:455-60. 2009..The aim of this study was to determine the incidence and the associated risk factors for SSI in HIV-infected patients...
Recurrent venous thrombosis in a patient with haemophilia A and HIV infectionKatleen de Gaetano Donati
Dept Infectious Diseases, Catholic University, Largo A. Gemelli, 8, 00168 Rome, Italy
Haematologica 87:ECR04. 2002
Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjectsAntonio Cassone
Department of Bacteriology and Medical Mycology, Istituto Superiore di Sanita, 00161 Rome, Italy
J Infect Dis 185:188-95. 2002..Thus, PIs exert an early, immune reconstitution-independent effect on Candida virulence in the oral cavities of HIV-positive subjects...
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: analysis of trends in prevalence and epidemiologyEvelina Tacconelli
Emerg Infect Dis 8:220-1. 2002
Epidemiological comparison of true methicillin-resistant and methicillin-susceptible coagulase-negative staphylococcal bacteremia at hospital admissionEvelina Tacconelli
Beth Israel Deaconess Medical Center and Division of Infectious Diseases, Harvard Medical School, Boston, Massachusetts 02215, USA
Clin Infect Dis 37:644-9. 2003....
Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysisEvelina Tacconelli
Division of Infectious Diseases, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA
Clin Infect Dis 37:1629-38. 2003..Mupirocin prophylaxis substantially reduces the rate of S. aureus infection in the dialysis population. Optimal regimens that minimize the emergence of mupirocin resistance need to be explored...
Preventing the influx of vancomycin-resistant enterococci into health care institutions, by use of a simple validated prediction ruleEvelina Tacconelli
Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
Clin Infect Dis 39:964-70. 2004..The goal of this study was to develop a validated prediction rule for identification of patients harboring vancomycin-resistant enterococci (VRE) at hospital admission...
Prediction of bacteremia using TREAT, a computerized decision-support systemMical Paul
Department of Medicine E, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel
Clin Infect Dis 42:1274-82. 2006..Prediction of bloodstream infection at the time of sepsis onset allows one to make appropriate and economical management decisions...
Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stayAbigail Fraser
Department of Medicine E, Rabin Medical Center, Beilinson Campus, Petah-Tiqva, Israel
Am J Med 119:970-6. 2006..006). CONCLUSION: Appropriate empirical antibiotic treatment is associated with a better survival and shortened duration of hospital stay in medical patients with bacterial infections...
The TREAT project: decision support and prediction using causal probabilistic networksLeonard Leibovici
Department of Medicine E, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel
Int J Antimicrob Agents 30:S93-102. 2007..In the present review we discuss the advantages of using causal probabilistic models for prediction and decision support, and the various decisions that were taken in the TREAT project...
Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trialMical Paul
Department of Medicine E, Rabin Medical Center, Beilinson Campus, 49100 Petah Tiqva, Israel
J Antimicrob Chemother 58:1238-45. 2006..Appropriate antibiotic treatment decreases mortality, while superfluous treatment is associated with antibiotic resistance. We built a computerized decision support system for antibiotic treatment (TREAT) targeting these outcomes...
Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issuesGiuseppe Cornaglia
Department of Pathology, University of Verona, Italy
Int J Antimicrob Agents 29:380-8. 2007....
The importance of addressing multidrug resistance and not assuming single-drug resistance in case-control studiesErika M C D'Agata
Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
Infect Control Hosp Epidemiol 27:670-4. 2006....
Prediction of specific pathogens in patients with sepsis: evaluation of TREAT, a computerized decision support systemMical Paul
Department of Medicine E, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel
J Antimicrob Chemother 59:1204-7. 2007..Prediction of bacterial infections and their pathogens allows for early, directed investigation and treatment. We assessed the ability of TREAT, a computerized decision support system, to predict specific pathogens...
